Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
SG monotherapy demonstrates a high response rate in PT-ineligible patients with...
Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows...
Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC ( Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA )
24 Feb 2023
ASCO GU 2023: Latest updates in mRCC
Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor...
ASCO GU 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor Grünwald and Prof Toni Choueiri )
18 Feb 2023
Nivolumab and salvage nivolumab plus ipilimumab for aRCC
Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center...
Nivolumab and salvage nivolumab plus ipilimumab for aRCC ( Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center, Georgetown, USA )
18 Feb 2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous...
Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA
Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma ( Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA )
16 Feb 2023
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )
7 Feb 2023
Management of HER2 positive metastatic breast cancer treatment algorithm
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
Management of HER2 positive metastatic breast cancer treatment algorithm ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )
31 Jan 2023
Immuno-radiotherapy: rationale and new perspectives for breast cancer patients
Prof Roberto Orecchia - University of Milan, Milan, Italy
Immuno-radiotherapy: rationale and new perspectives for breast cancer patients ( Prof Roberto Orecchia - University of Milan, Milan, Italy )
31 Jan 2023
Post neoadjuvant management in BRCA mutant breast cancer patients
Prof Banu Arun - MD Anderson Cancer Center, Houston, USA
Post neoadjuvant management in BRCA mutant breast cancer patients ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 6: EONS Sessions ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 5: GI Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation